Aicaigou LogoAicaigou LogoB2B WikiIndustrial Encyclopedia

BRCA1

Updated: 2026-07-22

Overview

The BRCA1 protein, encoded by the BRCA1 gene, is a crucial tumor suppressor that helps maintain genomic stability. It plays a central role in repairing double-strand DNA breaks through homologous recombination, a process vital for preventing cancerous mutations. Discovered in 1994, BRCA1 mutations are hereditary and significantly increase the lifetime risk of breast, ovarian, and other cancers. BRCA1 interacts with multiple proteins, including RAD51 and BARD1, to form complexes that orchestrate DNA repair. Its dysfunction leads to genomic instability, a hallmark of cancer. Approximately 5-10% of breast cancers are attributed to inherited BRCA1/2 mutations, making genetic testing a valuable tool for risk assessment.

Key Features

人乳腺癌易感蛋白1(BRCA-1)ELISA试剂盒灵敏度高GOY-0238E上海谷研实业有限公司

BRCA1 is a large protein with multiple functional domains, including a RING domain (for ubiquitin ligase activity) and BRCT domains (for protein-protein interactions). These domains enable its roles in DNA repair, transcriptional regulation, and chromatin remodeling. The protein localizes to DNA damage sites, where it recruits repair machinery. Notably, BRCA1 mutations are often loss-of-function, disrupting repair pathways. Over 1,000 pathogenic variants have been identified, with some founder mutations (e.g., 185delAG in Ashkenazi Jews) being population-specific. Testing for these mutations informs clinical decisions, such as enhanced surveillance or prophylactic surgeries.

商家经验真实案例 · 安全可信
根瘤固氮酶试剂盒
本文介绍根瘤固氮酶试剂盒的功能、应用场景及使用优势,帮助农业科研人员高效检测豆科植物固氮能力,优化种植方案。

Application Areas

BRCA1 testing is widely used in oncology to identify high-risk individuals and guide preventive strategies. For carriers, options include frequent MRI screenings, chemoprevention (e.g., tamoxifen), or risk-reducing mastectomies. The protein is also a target for PARP inhibitors, a class of drugs exploiting synthetic lethality in BRCA-deficient cancers. Beyond clinical care, BRCA1 research advances our understanding of DNA repair mechanisms. Studies explore its interactions with other tumor suppressors (e.g., TP53) and potential therapeutic vulnerabilities. Biotechnology firms develop assays to detect mutations with high accuracy, supporting precision medicine initiatives.

Precautions

笃玛 人乳腺癌易感蛋白1(BRCA-1)elisa试剂盒 科研检测上海笃玛生物科技有限公司

Genetic testing for BRCA1 mutations requires careful consideration. False positives/negatives can occur due to variants of uncertain significance (VUS) or technical limitations. Patients should undergo pre-test counseling to understand implications for themselves and relatives. Privacy concerns are paramount, as results may affect insurance eligibility in some regions. Additionally, not all mutation carriers develop cancer (penetrance varies), so risk estimates should be personalized. Laboratories must adhere to guidelines like those from the ACMG (American College of Medical Genetics) to ensure reliable reporting.

商家经验真实案例 · 安全可信
strem 1检测试剂盒
本文介绍strem 1检测试剂盒的基本特点、适用场景及操作注意事项,帮助用户了解其功能与潜在应用价值。

B2B Procurement Guide

For labs and hospitals procuring BRCA1 testing services, prioritize CAP/CLIA-certified providers with validated protocols. Key selection criteria include turnaround time (typically 2-4 weeks), comprehensiveness (testing for large rearrangements beyond sequencing), and bioinformatics support for variant interpretation. Costs vary by panel size (single-gene vs. multi-gene panels) and geographic market. Bulk purchasing or institutional contracts may reduce fees. Ensure providers offer clear reports with actionable recommendations and access to genetic counselors for result explanation.

Related Manufacturers